Select Publications

Books

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

Book Chapters

Tu S; Huynh W; Kiernan MC, 2024, 'Advances in Brain Imaging', in The Sage Handbook of Cognitive and Systems Neuroscience, SAGE Publications, pp. 533 - 552, http://dx.doi.org/10.4135/9781529616613.n32

Park SB; Kiernan MC, 2023, 'Chemotherapy-Induced Cranial Nerve Damage', in Cranial Nerves in Neurology A Comprehensive and Systematic Evaluation of Cranial Nerves Pathology and Specific Conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23

Vucic S; Kiernan MC, 2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138

Tu S; Kiernan MC, 2023, 'Chapter 14 Amyotrophic lateral sclerosis', in Imaging Neuroinflammation, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2

Vucic S; Kiernan MC, 2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer Nature, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1

Dharmadasa T; Huynh W; Kiernan MC, 2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia the Neuroscience of Dementia Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5

Huynh W; Lee M; Kiernan MC, 2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press (OUP), pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Taylor & Francis, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9

Hardiman O; Kiernan MC; Van den Berg LH, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders A Clinical Guide Second Edition, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8

huynh W; lee M; kiernan MC, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235

Huynh W; Lee M; Kiernan M, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press (OUP), pp. 224 - 237, http://dx.doi.org/10.1093/med/9780199673711.003.0019

Kiernan MC, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9

Vucic S; Kiernan MC, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138

, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Nature, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376

Kiernan MC; Lin CSY, 2012, 'Chapter 15 Nerve Excitability A Clinical Translation', in Aminoff's Electrodiagnosis in Clinical Neurology, Elsevier, pp. 345 - 365, http://dx.doi.org/10.1016/b978-1-4557-0308-1.00015-7

Farrar M; Kiernan MC, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2

Park SB; Kiernan MC, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b

Park SB; Kiernan MC, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3

Vucic O; Burke D; Kiernan MC, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104

Kiernan MC, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181

Lin CS; Kiernan MC; Burke D; Bostock H, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403

Burke D; Kiernan MC, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy 2 Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

KIERNAN MC; BURKE D; BOSTOCK H, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9

AL-CHALABI A; BAMIOU D-E; BANKS RW; BAROHN RJ; BENSTEAD TJ; BERGER AR; BERTHOLD C-H; BHARUCHA AE; BIRCH R; BONKOVSKY HL; BOOTH AM; BOSCH EP; BOSTOCK H; BRADKE F; BRADY RO; BRIMIJOIN S; BUCK D; BUNGE RP; BURKE D; BURKE JP; BURNS TM; CAMILLERI M; CARNEY JA; CHALK C; CHANCE PF; CHIU SY; COLLINS MP; COOTE JH; CORBETT JJ; CORNBLATH DR; COWEN T; CUDIA P; DARRAS BT; DAVIES JL; DE GROAT WC; DISPENZIERI A; DOMBOVY ML; DONAGHY M; DYCK PJ; DYCK PJB; ENGEL AG; ENGELSTAD J; FERRANTE MA; FRAHER JP; FREEMAN MW; FREEMAN R; FRITSCHE TR; GABREëLS-FESTEN A; GARDNER ED; GIANNINI C; GILDEN DH; GOEBEL HH; GOLD R; GRANT IA; GREGSON NA; GRIFFIN JW; GROVES MJ; HABERMANN TM; HAHN AF; HALL S; HALLIWILL JR; HANNA MG; HARDING AE; HARTUNG H-P; HERSKOVITZ S; HöKE A; HUGHES RAC; HUXLEY C; JACOBSON RR; JACOBY A; JESSEN KR; JOHNSON DM; JONES HR; JOYNER MJ; KATIRJI B; KAUFMAN KR; KELLY JJ; KENNEDY WR; KIERNAN MC; KIESEIER BC; KIMURA J; KING RHM; KISSEL JT; KLEIN CM; KLEIN CJ; KLEOPA KA; KLINGELE CJ; KREULEN DL; KYLE RA; LACROIX C; LAGERLUND TD; LAMBERT EH; LAWSON SN; LEAVITT JA; LEIGH PN; LLEWELYN JG; LOPATE G; LOW PA; LUPSKI JR; LUXON LM; MARTINI R; MATHIAS CJ; MCARTHUR JC; MCDONALD ES; MCLEOD JG; MCMANIS PG; MELTON LJ; MESSING A; MICHELS VV; MIRSKY R; O'BRIEN PC; O'HANLON GM; O'NEILL GN; PATERSON DJ; PESTRONK A; PLEASURE D; POLLARD JD; POLYDEFKIS M; POTTUMARTHY S; REILLY MM; ROBERTSON A; ROMAN GC; ROWBOTHAM MC; RYAN MM; RYDMARK M; SABIN TD; SAID G; SAPERSTEIN DS; SCARAVILLI F; SCHAUMBURG HH; SCHERER SS; SCHIFFMANN R; SCHMELZ M; SCOTT JJA; SHEIKH K; SHEPHERD JT; SHY ME; SINGER W; SMITH BE; SORENSON EJ; SPIES JM; STÅLBERG EV; STEVENS JC; STOLL G; SUAREZ GA; SUTER U; SWIFT TR; TAYLOR BV; TEFFERI A; THIBODEAU SN; THOMAS PK; THOMPSON PD; THORLAND EC; TOMLINSON DR; TOREBJÖRK E; TOYKA KV; TRONTELJ JV; TYLER KL; ULFHAKE B; VANHOUTTE PM; WANG AK; WARNER LE; WEBSTER HD; WEERASURIYA A; WENDELSCHAFER-CRABB G; WIJDICKS EFM; WILBOURN AJ; WILLISON HJ; WINDEBANK AJ; WITTE H; WOOD JD; YOUNGE BR; ZOCHODNE DW, 2005, 'Contributing Authors', in Peripheral Neuropathy, Elsevier, pp. v - xv, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50002-8

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129

Kiernan MC; Burke D, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366

Kiernan MC, 2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences Volumes 1 4, pp. V2-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3

Kiernan MC, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642

Burke DJ; Mogyoros I; Kiernan MC; Bostock H, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154

Burke DJ; Kiernan MC; Mogyoros I; Bostock H, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53

Journal articles

Gray EL; McGuiness O; Menadue C; Piper A; Wong K; Kiernan MC; Yee BJ, 2027, 'Diaphragm reserve utilisation in motor neurone disease: A novel ultrasound-derived physiological index', Respiratory Physiology and Neurobiology, 347, http://dx.doi.org/10.1016/j.resp.2026.104667

Kim SH; Noh MY; Kiernan MC, 2026, 'Neurodegeneration as an evolutionary trade-off: a biological constraint–aware therapeutic perspective', Molecular Neurodegeneration, 21, http://dx.doi.org/10.1186/s13024-026-00958-w

Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson RD; King T; Baron-Hay S; Kiernan MC; Barnes EH; Goldstein D; Park SB, 2026, 'Multifactorial Contributors to Dose Limiting and Post-Treatment Neurologic Toxicity During Chemotherapy Treatment', Neurology, 107, http://dx.doi.org/10.1212/WNL.0000000000218599

Vucic S; Cheah BC; Krishnan AV; Burke D; Kiernan MC, 2026, 'Corrigendum to “The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition” [Brain Res. 1273 (2009) 39–47]', Brain Research, 1889, http://dx.doi.org/10.1016/j.brainres.2026.150475

Kim WS; Timmins HC; Van Den Bosch L; Rothstein JD; Kiernan MC, 2026, 'Astrocytic Lipid Dysregulation in Amyotrophic Lateral Sclerosis', Cellular and Molecular Neurobiology, http://dx.doi.org/10.1007/s10571-026-01840-5

Pavey N; Tu S; Foster S; Geevasinga N; Calma A; Tsuji Y; Kiernan MC; Vucic S; Menon P, 2026, 'Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability', Clinical Neurophysiology, 190, http://dx.doi.org/10.1016/j.clinph.2026.2111949

Yoshitake M; Shibuya K; Prado M; Sobue G; Shahrizaila N; Kiernan M; Kim SH; Kulkantrakorn K; Nagashima K; Ogino M; Mikami T; Laing T-T; Wang J; Misawa S; Kuwabara S, 2026, 'Current practice of delivering bad news of amyotrophic lateral sclerosis diagnosis in Asian and Oceanian countries: an international survey from a neurologist’s perspective', BMC Neurology, http://dx.doi.org/10.1186/s12883-026-05433-z

Henden L; Chan Moi Fat S; Smith A; Li I; Nicholas TJ; Mrkela M; O'Shaughnessy D; Zussa Z; Grima N; McCann EP; Fifita JA; Topp SD; Iacoangeli A; Rowe DB; Nicholson GA; Dobson-Stone C; Kwok JB; Piguet O; Halliday GM; Troakes C; Al-Chalabi A; Shaw CE; Roxburgh RH; Kiernan MC; Pamphlett R; Liquet B; McRae AF; Lin T; Laing NG; Needham M; Schultz D; Mathers S; Vucic S; Henderson R; McCombe P; Henders A; Quinlan AR; Scotter EL; Smith BN; Blair IP; Williams KL, 2026, 'Identity-by-descent to resolve reduced penetrance and advance gene discovery in neurodegenerative disease', Brain, pp. awag326, http://dx.doi.org/10.1093/brain/awag326

Shrestha N; Munn Z; Calma A; Pavey N; Tsuji Y; Menon P; Padovani A; Risi B; Ferullo L; Filosto M; Jewett G; Shibuya K; Otani R; Shimizu T; Kuwabara S; Noto YI; Kitaoji T; Johnsen B; Shen D; Cui L; van den Berg LH; van Eijk RPA; van Damme P; Kiernan MC; Giles L; Vucic S, 2026, 'Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis', Journal of Neurology, 273, http://dx.doi.org/10.1007/s00415-026-14046-y

Hannaford AM; Supnet IE; Pavey N; Menon P; van den Bos MAJ; Kiernan MC; van Alfen N; Simon NG; Vucic S, 2026, 'Muscle Ultrasound Is a Sensitive Outcome Measure in ALS', Muscle and Nerve, 74, pp. 590 - 599, http://dx.doi.org/10.1002/mus.70317

Isik FI; Pickford R; Timmins HC; Piguet O; Halliday GM; Kiernan MC; Kim WS, 2026, 'Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum', FEBS Open Bio, 16, pp. 1550 - 1562, http://dx.doi.org/10.1002/2211-5463.70232

D'Silva A; Herbert K; Balaji L; He JM; Kandula T; Sampaio HA; Teoh HL; Tantsis E; Sohn J; Briggs N; Ning N; Kiernan MC; Kariyawasam DS; Farrar MA, 2026, 'The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy', Annals of Neurology, 100, pp. 109 - 122, http://dx.doi.org/10.1002/ana.78207

Swart G; Garg N; Yiannikas C; Vucic OS; Pollard J; Carroll A; Silsby M; Kiernan M; Spies J; Park S, 2026, 'Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P7-9.003)', Neurology, 106, http://dx.doi.org/10.1212/wnl.0000000000217482

Swart G; Garg N; Skolka MP; Yiannikas C; Vucic S; Pollard JD; Carroll AS; Silsby M; Spies J; Kiernan MC; Klein CJ; Park SB, 2026, 'Application of a Clinical-Electrophysiological Model for Identifying Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Australian Cohort', Journal of the Peripheral Nervous System, 31, http://dx.doi.org/10.1111/jns.70125

Henders AK; Ziser L; Garton FC; Adams L; Ernst K; Furlong S; Heads JA; Heggie S; Krasniqi R; Bhadravathi Lokeshappa M; Mazumder S; McNamara E; MacShane A; Mekhael L; Nunn L; Orden B; Ryder J; Thorpe K; Toubia M; Wallace LM; Wickremeratne D; Windebank E; Benyamin B; Ngo S; Nicholson G; Pamphlett R; Steyn FJ; Visscher PM; Willams KL; Henderson R; Kiernan MC; Laing N; Mathers S; McCombe PA; Needham M; Rowe D; Schultz D; Talman P; Vucic S; Blair IP; McRae AF; Wray NR, 2026, 'Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile', BMJ Open, 16, http://dx.doi.org/10.1136/bmjopen-2025-110906

Calma AD; Pavey N; Silva CS; Tsuji Y; Ghapar AA; Morris K; Kiernan MC; Farrar MA; Menon P; Vucic S, 2026, 'Utility of Far-Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy', Muscle and Nerve, 73, pp. 1089 - 1095, http://dx.doi.org/10.1002/mus.70231


Back to profile page